PMA device
FARASTAR Pulsed Field Ablation (PFA) Generator
Farapulse, Inc. · Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI, Class III) · First FDA decision Sep 24, 2025, newest Sep 24, 2025Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
5
Naming "FARASTAR Pulsed Field"
MAUDE reports
46
Brand "FARASTAR Pulsed Field", since 2015
PubMed studies
0
Mentioning "FARASTAR Pulsed Field"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FARASTAR Pulsed Field Ablation (PFA) Generator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- FARASTAR Pulsed Field Ablation (PFA) Generator; FARASTAR Mapping System Module (MSM); FARASTAR Recording System ModulPMA supplement
P230030-S013 · Decided Sep 24, 2025 · 90 days after receipt · Normal 180 Day Track
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "FARASTAR Pulsed Field", any status and sponsor, newest update first.
- Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-AsiaActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT06686485 · 433 participants (planned) · Start Mar 18, 2025 · Primary completion Oct 31, 2026
Device: FARAPULSE™ PFA system and WATCHMAN LAAC Delivery Systems · For: Concomitant Procedures; Atrial Fibrillation; PFA and 1 more
Sites: Suzhou, China; Beijing, China; Chengdu, China · 37 sites in all
Boston Scientific CorporationPublic (BSX)
NCT07444320 · 200 participants (planned) · Start Feb 12, 2026 · Primary completion Feb 2028
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System · For: Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation
Sites: Split, Croatia; Prague, Czechia; Hong Kong, Hong Kong · 4 sites in all
- Atrial Remodeling After PFA Substrate Modification for Persistent AF (PeAF)Enrolling by invitation
Taipei Veterans General Hospital, TaiwanGovernment (non-federal)
NCT07675395 · 30 participants (planned) · Start Jul 1, 2026 · Primary completion Dec 31, 2028
Device: Pulsed-Field Ablation with FARAWAVE Catheter System · For: Persistent Atrial Fibrillation; Atrial Fibrillation (AF); Atrial Remodeling and 1 more
Sites: Taipei, Taiwan
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "FARASTAR Pulsed Field", and for the whole product code for context.
This brand
46 reports: 43 malfunction, 3 injury, 0 death
Whole product code QZI
10,522 reports: 5,457 malfunction, 4,777 injury, 245 death
Newest reports for this brand
- FARASTAR Pulsed Field Ablation GeneratorMalfunction
2124215-2026-57150 · Received Oct 27, 2026 · Event dated Oct 17, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Nonstandard Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- FARASTAR Pulsed Field Ablation GeneratorMalfunction
2124215-2026-55586 · Received Oct 20, 2026 · Event dated Sep 15, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Electrical /Electronic Property Problem; Nonstandard Device; Power Problem; Data Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- FARASTAR Pulsed Field Ablation GeneratorMalfunction
2124215-2026-48208 · Received Sep 9, 2026 · Event dated Aug 18, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Nonstandard Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2750-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
- FARASTAR Pulsed Field Ablation Generator, Product ID M004PFCE61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2751-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
- FARASTAR PFA Generator, Product ID M004PFCE61M460; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2752-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
2 more recall records with a free account
Published research
The most relevant PubMed records for "FARASTAR Pulsed Field"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QZI.
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation CatheterFarapulse, Inc. · PMA 2026
- Volt PFA SystemAbbott Medical · PMA 2026
- VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)Biosense Webster, Inc. · PMA 2026
- Sphere-9 Catheter and Affera Ablation SystemMedtronic, Inc. · PMA 2026
- PulseSelect Pulsed Field Ablation (PFA) systemMedtronic, Inc. · PMA 2026
- Globe® Catheter and Globe® Pulsed Field SystemKardium, Inc. · PMA 2026
- PulseSelect Pulse Field Ablation (PFA) CatheterMedtronic, Inc. · PMA 2026
- Globe® Pulsed Field SystemKardium, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.